A word about dilution in RFMK.
Read this part of the shareholder update carefully.
Revenue Sharing and Compensation issues have been lengthy to work through. Understandably, both sides want a good deal because of the potential for significant revenues from sales of the CannaCig. We want a GOOD DEAL for RFMK. We want to make sure that we get our fair share for our Company and our shareholders. We are not going to rush a deal to completion for the sake of rushing an announcement out there and risk getting a bad deal. At the same time, the distributor we are working with has very significant resources and they want a good deal too. We have worked through these issues and execution of the contract is imminent and I do mean imminent. The announcement of the execution of the contract can come as early Monday. However, again, our main concern is having all the bases covered with nothing left to question or interpretation.
This to me sounds like the distributor will provide the funding through this joint venture. Dilution has already beed addressed by the company and their stance is that they don't expect to dilute, or do any kind of reverse split. After all, in prior updates they even mentioned how they wanted to save money by using the existing Omicron design when they were trying to get this completed with THC Scientific. I think they are working hard to make this the most profitable not only for shareholders, but themselves.
Rec
AI
